195 Recruiting Melanoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Melanoma Studies
Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
📍 Vanderbitl-Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔In Vivo Real-time Detection of Circulating Melanoma Cells
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
📍 Centro Oncologico Korben — CABA, Buenos Aires
View Study & Checklist ➔Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
📍 Saint John's Health Center - John Wayne Cancer Institute (JWCI) — Santa Monica, California
View Study & Checklist ➔NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
📍 Adventist Health System/Sunbelt, Inc. — Orlando, Florida
View Study & Checklist ➔Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
📍 University of Louisville — Louisville, Kentucky
View Study & Checklist ➔Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
📍 The Angeles Clinic — Los Angeles, California
View Study & Checklist ➔War on Melanoma™ Public Health & Education Campaign
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
📍 Call for Information (Investigational Site 0019) — Aurora, Colorado
View Study & Checklist ➔A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
📍 The Angeles Clinic and Research Institute - California — Los Angeles, California
View Study & Checklist ➔A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
📍 Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
📍 BCCA - Abbotsford — Abbotsford British Columbia, British Columbia
View Study & Checklist ➔Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
📍 The Kirklin Clinic of UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔In Vivo Liquid Biopsy of Melanoma (Cytophone)
📍 SSM Health Dean Medical Group Specialty Services — Madison, Wisconsin
View Study & Checklist ➔Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma
📍 M.D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.
📍 California Pacific Medical Center Research Institute — San Francisco, California
View Study & Checklist ➔Treating Patients With Melanoma and ALK Alterations With Ensartinib
📍 Memorial Sloan Kettering Monmouth — Middletown, New Jersey
View Study & Checklist ➔Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
📍 Intermountain Medical Center — Murray, Utah
View Study & Checklist ➔Transfer of Genetically Engineered Lymphocytes in Melanoma Patients
📍 Loyola University Medical Center — Maywood, Illinois
View Study & Checklist ➔A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
📍 Local Institution - 0125 — Phoenix, Arizona
View Study & Checklist ➔A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Dabrafenib and/or Trametinib Rollover Study
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of IBI363 in Subjects with Advanced Solid Malignancies
📍 University of California, San Francisco (UCSF) — San Francisco, California
View Study & Checklist ➔A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
📍 James Graham Brown Cancer Center-University of Louisville — Louisville, Kentucky
View Study & Checklist ➔